Prothix Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Prothix General Information

Description

Developer of bio-pharmaceutical products intended to give protein therapeutics for inflammatory and coagulation disorders. The company's bio-pharmaceuticals are monoclonal antibody products that include humanization and de-immunization of human cells sensitized with anti-human leukocyte antigen antibodies, enabling medical professionals to monitor and treat thromboembolic, inflammatory, and coagulation disorders.

Contact Information

Website
www.prothix.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Warmonderweg 23
  • 2334 AB Leiden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Warmonderweg 23
  • 2334 AB Leiden
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prothix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 24-Mar-2023 Completed Out of Business
2. Early Stage VC 15-Aug-2011 Completed Generating Revenue
1. University Spin-Out 01-Jan-2008 Completed Startup
To view Prothix’s complete valuation and funding history, request access »

Prothix Patents

Prothix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190106509-A1 Monoclonal antibodies against the active site of factor xi and uses thereof Active 23-Mar-2016
US-11059905-B2 Monoclonal antibodies against the active site of factor xi and uses thereof Active 23-Mar-2016
JP-7028471-B2 Monoclonal antibody against the active site of factor xi and its use Active 23-Mar-2016
EP-3433279-A1 Monoclonal antibodies against the active site of factor xi and uses thereof Pending 23-Mar-2016
JP-2019516395-A Monoclonal antibodies against the active site of factor xi and their use Active 23-Mar-2016 C07K16/36
To view Prothix’s complete patent history, request access »

Prothix Investments (1)

Prothix’s most recent deal was a Joint Venture with Broteio.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Broteio Joint Venture Drug Discovery
To view Prothix’s complete investments history, request access »

Prothix FAQs

  • When was Prothix founded?

    Prothix was founded in 2008.

  • Where is Prothix headquartered?

    Prothix is headquartered in Leiden, Netherlands.

  • What industry is Prothix in?

    Prothix’s primary industry is Drug Discovery.

  • Is Prothix a private or public company?

    Prothix is a Private company.

  • What is Prothix’s current revenue?

    The current revenue for Prothix is .

  • How much funding has Prothix raised over time?

    Prothix has raised $942K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »